- Home
- MDAI vs DXR Comparison
MDAI vs DXR Comparison
Compare MDAI & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDAI
- DXR
- Stock Information
- Founded
- MDAI 2013
- DXR 1970
- Country
- MDAI United States
- DXR United States
- Employees
- MDAI 78
- DXR N/A
- Industry
- MDAI Medical/Dental Instruments
- DXR Medical/Dental Instruments
- Sector
- MDAI Health Care
- DXR Health Care
- Exchange
- MDAI Nasdaq
- DXR Nasdaq
- Market Cap
- MDAI 33.1M
- DXR 36.4M
- IPO Year
- MDAI N/A
- DXR N/A
- Fundamental
- Price
- MDAI $1.23
- DXR $7.43
- Analyst Decision
- MDAI Strong Buy
- DXR Strong Buy
- Analyst Count
- MDAI 2
- DXR 1
- Target Price
- MDAI $4.75
- DXR $25.00
- AVG Volume (30 Days)
- MDAI 149.5K
- DXR 4.9K
- Earning Date
- MDAI 05-13-2025
- DXR 01-01-0001
- Dividend Yield
- MDAI N/A
- DXR N/A
- EPS Growth
- MDAI N/A
- DXR 86.16
- EPS
- MDAI N/A
- DXR 0.11
- Revenue
- MDAI $29,581,000.00
- DXR $119,714.00
- Revenue This Year
- MDAI N/A
- DXR N/A
- Revenue Next Year
- MDAI $102.58
- DXR N/A
- P/E Ratio
- MDAI N/A
- DXR $68.72
- Revenue Growth
- MDAI 63.83
- DXR N/A
- 52 Week Low
- MDAI $0.82
- DXR $6.55
- 52 Week High
- MDAI $3.25
- DXR $10.00
- Technical
- Relative Strength Index (RSI)
- MDAI 40.42
- DXR 50.72
- Support Level
- MDAI $1.25
- DXR $7.10
- Resistance Level
- MDAI $1.32
- DXR $7.74
- Average True Range (ATR)
- MDAI 0.05
- DXR 0.29
- MACD
- MDAI 0.00
- DXR 0.00
- Stochastic Oscillator
- MDAI 28.57
- DXR 68.18
About MDAI Spectral AI Inc.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.